Atlas Trials

Post-Polycythemia Vera

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Post-Polycythemia Vera

RecordFirmDate
An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib (NCT03952039)Celgene2019-09-09
Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis (NCT01423058)Sierra Oncology LLC - a GSK company2011-08-01
A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis (NCT00931762)Novartis Pharmaceuticals2009-08-31

Track Post-Polycythemia Vera automatically

Every clearance here is in the API, with alerts when new ones post.